Helen Fisher

Helen Fisher

Director/Miembro de la Junta en CALIX LIMITED .

Fortuna: 58 873 $ al 31/05/2026

Commercial Services
Consumer Services
Health Technology

Perfil

Helen Fisher is currently the Managing Director & CEO at BCIF Pty Ltd., the Chairman-Victorian Branch at AusBiotech Ltd., an Independent Non-Executive Director at Calix Ltd., a Member of Chartered Accountants Australia & New Zealand, and a Member of The American Chamber of Commerce in Australia.
Previously, she served as an Independent Non-Executive Director at Sienna Cancer Diagnostics Ltd. from 2018 to 2020, a Non-Executive Director at INOVIQ Ltd. in 2020, and an Independent Non-Executive Director at Paradigm Biopharmaceuticals Ltd. from 2021 to 2024.
She also worked as a Partner at Deloitte & Touche (Australia).
Ms. Fisher holds graduate degrees from the University of Melbourne and The University of New South Wales.

Participaciones conocidas en empresas públicas

EmpresaFechaNúmero de accionesValoraciónFecha de valoración
CALIX LTD.
0,08 %
05/12/2025 168.710 ( 0,08 % ) 58 873 $ 31/05/2026

Cargos activos de Helen Fisher

EmpresasCargoInicio
CALIX LIMITED Director/Miembro de la Junta 22/09/2020
Director Ejecutivo -
Corporate Officer/Principal -
Corporate Officer/Principal -
Corporate Officer/Principal -

Antiguos cargos conocidos de Helen Fisher.

EmpresasCargoFin
PARADIGM BIOPHARMACEUTICALS LIMITED Director/Miembro de la Junta 04/03/2024
INOVIQ LTD Director/Miembro de la Junta 25/11/2020
SIENNA CANCER DIAGNOSTICS LIMITED Director/Miembro de la Junta 01/07/2020
Corporate Officer/Principal -
Ver el detalle de la experiencia de Helen Fisher.

Formación de Helen Fisher.

Experiencias
Funciones ocupadas

Activas

Inactivas

Empresas cotizadas

Empresas privadas

Relaciones

94

Relaciones de 1er grado

11

Empresas vinculadas al 1er grado

Hombre

Mujer

Administradores

Ejecutivos

Empresas relacionadas

Empresas privadas11

Consumer Services

Consumer Services

Commercial Services

Commercial Services

Health Technology

Producer Manufacturing

Health Technology

Commercial Services

Finance

Health Services

Finance